Strike down to zero
migraine pain
with Ubrelvy®

Pain relief at 2 hours was demonstrated in 62% (UBRELVY 50 mg) vs 49% (placebo) when taken immediately or within 4 hours of onset3,4

Pain freedom at 2 hours (co-primary endpoint) was demonstrated in 21% (UBRELVY 50 mg) vs 13% (placebo).3 Sustained pain freedom from 2 to 24 hours (secondary endpoint) was achieved in 14% (UBRELVY 50 mg) vs 8% (placebo)1

UBRELVY has been prescribed over 2 million times by more than 80,000 HCPs, treating over 500,000 patients3

Ubrelvyhcp Hero Banner
ubrelvyhcp stamp.svg

THE POWER OF zero
migraine pain3
TAKEN ANYTIME, ANYWHERE1*

POWERFUL:
Zero pain, sustained1,3

Pain freedom at 2 hours (co-primary endpoint) was demonstrated in 21% (UBRELVY® 50 mg) vs 13% (placebo).1,3 Sustained pain freedom from 2 to 24 hours (secondary endpoint) was achieved in 14% (UBRELVY 50 mg) vs 8% (placebo)1,3,4

RAPID:
Quick pain relief1

Pain relief at 2 hours was demonstrated in 62% (UBRELVY 50 mg) vs 49% (placebo) when taken immediately or within 4 hours of onset1,3,5

PRE-HEADACHE:
Clinical evidence3

Absence of headache pain of moderate to severe intensity within 24 hours after dosing in the pre-headache phase (primary endpoint)3

INDICATION

UBRELVY® (ubrogepant) is indicated for the acute treatment of migraine with or without aura in adults. UBRELVY is not indicated for the preventive treatment of migraine.

Streamline the prescribing process

Get patients started

Once you've decided to prescribe UBRELVY, enable access for your patients with our U-CONCIERGE program and learn how eligible patients may pay as little as $0—all pills, all fills.

Help enable access
Prescribe the 16-count

16-count pack is available for your UBRELVY patients

Migraine attacks can be unpredictable.6 Prepare your patients with a 16-count package of UBRELVY 100 mg tablets.

View dosing
See the results of administering UBRELVY during the pre-headache phase.

Many patients experience
pre-headache symptoms7

See the results of administering UBRELVY during the pre-headache phase of a migraine attack.

Explore pre-headache data

*In clinical studies, patients took UBRELVY within 4 hours of a migraine attack.5

Patient out-of-pocket costs may vary. Terms and Conditions apply. This offer is only valid for commercially insured patients. Offer not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs.